NLRP3 and metabolic dysfunction-associated steatotic liver disease: Since previous studies have shown that the formation and activation of NLRP3 inflammasomes in fibroblasts including HSCs may trigger the development of liver fibrosis [4], we determined whether these inflammasome-triggered fibrogenetic effects occur in NAFLD.